Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis and Biological Evaluation of Isoxazoline and Isoxazole Derivatives as 5-HT2A and 5-HT2C Receptor Ligands

  • Youn, Hae-Suk (Life Sciences Division, Korea Institute of Science and Technology) ;
  • Lee, Eun-Ju (Department of Chemistry, College of Natural Sciences, Sangmyung University) ;
  • Lee, Jie-Eun (Life Sciences Division, Korea Institute of Science and Technology) ;
  • Park, Woo-Kyu (Pharmaceutical Screening Research Team, Korea Research Institute of Chemical Technology) ;
  • Baek, Du-Jong (Department of Chemistry, Inha University) ;
  • Cho, Yong-Seo (Department of Chemistry, College of Natural Sciences, Sangmyung University) ;
  • Koh, Hun-Yeong (Life Sciences Division, Korea Institute of Science and Technology) ;
  • Choo, Hyun-Ah (Pharmaceutical Screening Research Team, Korea Research Institute of Chemical Technology) ;
  • Pae, Ae-Nim (Life Sciences Division, Korea Institute of Science and Technology)
  • Published : 2009.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Artigas, F.; Nutt, D. J.; Shelton, R. Psychopharmacology Bull. 2002, 36, 123
  2. Gillman, P. K. Brit. J. Pharmacol. 2007, 151, 737 https://doi.org/10.1038/sj.bjp.0707253
  3. Lane, R.; Baldwin, D.; Preskorn, S. J. Psychopharmacology 1995, 9, 163
  4. Montgomery, S. Int. J. Psychiat. Clin. 2006, 10, 5 https://doi.org/10.1080/13651500600637049
  5. Adell, A.; Castro, E.; Celada, P.; Bortolozzi, A.; Pazos, A.; Artigas, F. Drug Discov. Today 2005, 10, 578 https://doi.org/10.1016/S1359-6446(05)03398-2
  6. Romero, L.; Celada, P.; Martin-Ruiz, R.; Diaz-Mataix, L.; Mourelle, M.; Delgadillo, J.; Hervas, I.; Artigas, F. Neuropsychopharmacology 2003, 28, 445 https://doi.org/10.1038/sj.npp.1300062
  7. Boothman, L.; Mitchell, S. N.; Sharp, T. Neuropharmacology 2006, 50, 726 https://doi.org/10.1016/j.neuropharm.2005.11.020
  8. Boothman, L.; Allers, K. A.; Rasmussen, K.; Sharp, T. Brit. J. Pharmacol. 2004, 139, 998
  9. Stout, S. C.; Owens, M. J.; Nemeroff, C. B. Ann. Rev. Pharmacol. Toxicol. 2001, 41, 877 https://doi.org/10.1146/annurev.pharmtox.41.1.877
  10. Overstreet, D. H.; Griebel, G.; Eur. J. Pharmacol. 2004, 497, 49 https://doi.org/10.1016/j.ejphar.2004.06.035
  11. Sharp, T.; Boothman, L.; Raley, J.; Queree, P. TRENDS Pharmacol. Sci. 2007, 28, 629 https://doi.org/10.1016/j.tips.2007.10.009
  12. Temel, Y.; Boothman, L. J.; Blokland, A.; Magill, P. J.; Steinbusch, H. W. M.; Visser-Vandewelle, V.; Sharp, T. PNAS 2007, 104, 17087 https://doi.org/10.1073/pnas.0704144104
  13. Artigas, F.; Bortolozzi, A. Neuropsychopharmacology 2003, 28, 421 https://doi.org/10.1038/sj.npp.1300061
  14. Bala, K.; Hailes, H. C. Synthesis 2005, 19, 3423
  15. Browne, M. F.; Shriner, R. L. J. Org. Chem. 1957, 22, 1320 https://doi.org/10.1021/jo01362a007
  16. David, A.; Steer, D.; Bregant, S.; Devel, L.; Makaritis, A.; Beau, F.; Yiotakis, A.; Dive, V. Angew. Chem. Int. Ed. 2007, 46, 3275 https://doi.org/10.1002/anie.200604408
  17. Cha, M. Y.; Choi, B. C.; Kang, K. H.; Pae, A. N.; Choi, K. Y.; Cho, Y. S.; Koh, H. Y.; Lee, H.-Y.; Jung, D.; Kong, J. Y. Bioorg. Med. Chem. Lett. 2002, 12, 1327 https://doi.org/10.1016/S0960-894X(02)00179-8
  18. Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. J. Org. Chem. 1996, 61, 3849 https://doi.org/10.1021/jo960057x
  19. Pazos, A.; Hoyer, D.; Palacios, J. M. Eur. J. Pharmacol. 1985, 106, 539 https://doi.org/10.1016/0014-2999(84)90057-8
  20. Park, W. K.; Jeong, D.; Cho, H.; Lee, S. J.; Cha, M. Y.; Pae, A. N.; Choi, K. I.; Koh, H. Y.; Kong, J. Y. Pharmacol. Biochem. Behav. 2005, 82, 361 https://doi.org/10.1016/j.pbb.2005.09.006
  21. Borsini, F.; Meli, A. Phychopharmacology 1988, 94, 147
  22. Porsolt, R. D.; Bertin, A.; Jalfre, M. Arch. Int. Pharmacodyn. Ther. 1977, 229, 327

Cited by

  1. Receptor Antagonists vol.32, pp.7, 2011, https://doi.org/10.5012/bkcs.2011.32.7.2449
  2. receptors vol.32, pp.spc8, 2011, https://doi.org/10.5012/bkcs.2011.32.8.2861
  3. Versatile Synthesis of Disubstituted Triazole Library for Dopamine and Serotonin Receptor Ligands vol.32, pp.spc8, 2011, https://doi.org/10.5012/bkcs.2011.32.8.3101
  4. A Facile Greener Assisted Protocol for the Synthesis of Some New 4-aryl-(5-chloro-3-Methyl-1-phenyl-1H-Pyrazol-4-yl)-4,5-dihydroisoxazol-3-yl) Derivatives and their in vitro Antimicrobial Activity vol.56, pp.2, 2012, https://doi.org/10.5012/jkcs.2012.56.2.246
  5. -Indol-3-yl)-3-(substituted aryl)-4,5-dihydroisoxazoline Derivatives vol.2013, pp.2090-9071, 2013, https://doi.org/10.1155/2013/637205
  6. Synthesis and Biological Evaluation of Substituted Pyrazole Constrained Piperazine Derivative Library for Dopamine Receptor Antagonist vol.37, pp.12, 2016, https://doi.org/10.1002/bkcs.11012
  7. ChemInform Abstract: Synthesis and Biological Evaluation of Isoxazoline and Isoxazole Derivatives as 5-HT2A and 5-HT2C Receptor Ligands. vol.41, pp.1, 2010, https://doi.org/10.1002/chin.201001177